These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9627698)

  • 1. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs.
    van de Kerkhof PC
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):78-81. PubMed ID: 9627698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
    Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
    Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.
    Mommers JM; Castelijns FA; Seegers BA; Van Rossum MM; Van Hooijdonk CA; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1998 Sep; 139(3):468-71. PubMed ID: 9767292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on vitamin D3 analogues in the treatment of psoriasis.
    van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1998; 11(1):2-10. PubMed ID: 9603664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A left/right comparison of twice-daily calcipotriol ointment and calcitriol ointment in patients with psoriasis: the effect on keratinocyte subpopulations.
    Franssen ME; de Jongh GJ; van Erp PE; van de Kerkhof PC
    Acta Derm Venereol; 2004; 84(3):195-200. PubMed ID: 15202835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.
    van der Vleuten CJ; de Jong EM; van de Kerkhof PC
    Arch Dermatol Res; 1996 Jun; 288(7):366-72. PubMed ID: 8818184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histometric assessment of psoriatic plaques treated by vitamin D3 derivatives.
    Uhoda I; Quatresooz P; Hermanns-Lê T; Piérard-Franchimont C; Arrese JE; Piérard GE
    Dermatology; 2003; 206(4):366-9. PubMed ID: 12771488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparameter flow cytometry as a tool to evaluate antipsoriatic therapy.
    Glade CP; van Erp PE; Boezeman JB; van de Kerkhof PC
    Br J Dermatol; 1997 Sep; 137(3):367-75. PubMed ID: 9349331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase-positive cells in psoriatic epidermis during treatment with calcitriol (1alpha,25 dihydroxy vitamin D3) and tacalcitol (1alpha,24 dihydroxy vitamin D3).
    Gerritsen MJ; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 1995 Oct; 133(4):656-9. PubMed ID: 7577606
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
    Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
    Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation is the main epidermal target in the treatment of psoriatic plaques with once daily application of tacalcitol ointment.
    Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PJ; van de Kerkhof PC
    Acta Derm Venereol; 1999 Mar; 79(2):111-4. PubMed ID: 10228627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice.
    Sato H; Ogino Y; Takagi H; Hata J; Asano S; Ohta T; Komoriya K
    J Dermatol; 2003 Jul; 30(7):510-24. PubMed ID: 12928540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury.
    Mommers JM; ter Meulen AC; van Erp PE; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):174-81. PubMed ID: 10420137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol inhibits the proliferation of hyperproliferative CD29 positive keratinocytes in psoriatic epidermis in the absence of an effect on the function and number of antigen-presenting cells.
    Jensen AM; Lladó MB; Skov L; Hansen ER; Larsen JK; Baadsgaard O
    Br J Dermatol; 1998 Dec; 139(6):984-91. PubMed ID: 9990360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions.
    van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study.
    Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC
    Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.